Envelope glycoprotein E2 (gp51 to gp54) is the major neutralizing antigen of pestiviruses, which include classical swine fever virus (CSFV), bovine viral diarrhoea virus (BVDV), and border disease virus (BVD). Previous studies carried out using a panel of monoclonal antibodies raised against CSFV strain Brescia have revealed the existence of four antigenic domains, A to D, of the E2 protein, all of which are located at the N-terminal half of the molecule. Here we report the detailed mapping, using three complementary techniques, of a novel linear epitope located at the C-terminal part of the molecule, which reacted with a monoclonal antibody (4-9D4) as well as polyclonal animal sera. This epitope is highly conserved in the three different members of pestiviruses and hence can be used as a genus-specific diagnosis tool. The observation that this epitope is not accessible on the native virus surface, together with its C-terminal location, supports a recently proposed structural model, indicating that the C-terminal part of E2 is membrane-bound while the N-terminal half of the molecule is exposed on the virus surface. ᭧
The genus Pestivirus of the Flaviridae family is com-candidate for recombinant vaccine development as well posed of three members, i.e., classical swine fever virus as for serum diagnosis. (CSFV), bovine viral diarrhoea virus (BVDV), and border Using mAbs directed against the E2 protein of CSFV disease virus (BDV) (1). Pestiviruses are structurally and strain Brescia, four antigenic domains, A to D, have been antigenically closely related. Antibodies derived from aniidentified on the E2 protein (15) (16) (17) (18) . All of them are lomals infected with one group of viruses often cross-react cated in the N-terminal half of the molecule between with the other members of the genus (2). However, most amino acid residues 690 and 866. The N-terminal half of monoclonal antibodies (mAb) directed against structural the molecule has been shown to be important for virus proteins are able to discriminate between CSFV and neutralization (15, 18) . From their epitope mapping data, BVDV (3-5).
Van Rijn et al. (18) have recently proposed a structural The genome of pestiviruses is a positive-stranded RNA model for the E2 protein, which provides the location of of about 12.5 kb (6) (7) (8) . The genome codes for a single the four antigenic domains, the potential glycosylation open reading frame (ORF) flanked by two short noncodsites, and the important disulfide bonds. In this model, ing regions. The open reading frame is translated into a the C-terminal 35 amino acid residues are buried in the polyprotein of approximately 4000 amino acids in length, membrane envelope. which is then processed into individual polypeptides by
In this paper we report the identification and detailed virus-and cell-encoded proteases (9). It has been sugmapping of a linear epitope located at the C-terminal gested that the nomenclature for pestivirus glycoproteins part of the E2 protein. This represents a new antigenic to change from molecular mass-based names (e.g., gp53) region of the E2 protein which has not been reported to position-based names (e.g., E2) (9). The coding regions before. Our epitope mapping results are consistent and for the three envelope glycoproteins E0 (gp44-48), E1 complementary to the previous data which led to the (gp31-33), and E2 (gp51-54) have been mapped for proposal of the above mentioned structural model of E2. CSFV (8-10). The major envelope glycoprotein E2 is lo-
The mAb 4-9D4 used in this study was raised in mice cated between amino acid residues 690 and 1060 of the against a denatured recombinant E2 protein produced single ORF polyprotein (7, 11) . Among the three envelope in yeast using an cDNA clone coding for amino acid glycoproteins, E2 is the most antigenic, and an immune residues 544-1093 of E2 protein from CSFV strain Weyresponse against E2 alone is sufficient for protection bridge (19; also M. Yu and J. White, unpublished results). (12) (13) (14) . Therefore, E2 has long been considered an ideal Initial characterization of the mAb indicated that it recognized a linear epitope of the E2 protein, which is not accessible in the native virus. In Western blot, mAb 4- a 21-aa peptide (KNKYYEPRDSYFQQYMLKGEY) which corresponds to amino acid residues 991-1012 of the CSFV E2 protein (7, 19) . The 8th clone contained a larger insert corresponding to amino acid residues 985-1051, which covered the smaller 21-aa insert sequence isolated in the other 7 clones. Further analysis was, therefore, concentrated on the clone containing the 21-aa insert, which was named f1CSFV-D4. Recombinant phage particles were purified from f1CSFV-D4 by three times PEG precipitation and tested for their reactivity with polyclonal animal sera. Positive results were obtained, in ELISA and Western blot, with polyclonal sera raised f88-4 (23). After two rounds of affinity selection as described (20, 22) , positive clones were picked up by a colony blotting procedure (24), followed by confirmation 9D4 not only reacted with the recombinant E2 protein originally used for immunization (data not shown), but with ELISA analysis. Twelve positive clones were then selected for further analysis by sequencing. As shown also reacted with viral E2 proteins derived from all pestivirus strains available for testing in our laboratory (see in Fig. 2A , these clones represent 10 different classes of inserts, all of them contained a 4-amino acid residue Fig. 1 ). The mAb failed to react in ELISA with purified native virus particles (C. Morrissy, unpublished results). core consensus region, highly homologous to the YYEP sequence in the E2 protein of CSFV. These results not However, positive ELISA results could be obtained after the purified virions were first treated with 1% NP-40 for only corroborated the data obtained above from the E2targeted phage display epitope library, but also revealed 2 hr at room temperature. When cell monolayer was treated with 2-3% formalin and 0.1% NP-40, positive re-that YYEP is the critical binding site for 4-9D4. It is interesting to note that there was not much sequence homol-sults were also obtained in immunoperoxidase test (C. Morrisy, unpublished results). These results suggest that ogy in the flanking regions of the 15-mer inserts, suggesting that the YYEP tetra-peptide is sufficient for mAb the 4-9D4 epitope is not accessible on the surface of the native virions.
4-9D4 recognition. The results also indicated that among the YYEP tera-peptide sequence, the second position To map the epitope defined by mAb 4-9D4, three complementary mapping techniques were employed. These (occupied by Y) allows limited sequence variation (see more discussion below). include the use of two different types of phage display epitope libraries followed by the application of overlap-Sequence alignment, in Fig. 2B , for the YYEP-region from E2 proteins of all pestiviruses whose E2 gene has ping synthetic peptides in competition ELISA analysis.
First, a gene-targeted phage display epitope library been sequenced indicated a strong sequence conservation in this region. This provides molecular evidence for was constructed using the procedures previously developed by our group (20, 21) . Briefly, using the 1.7-kb cDNA our initial finding that mAb 4-9D4 was able to react with E2 proteins from all the pestiviruses available for testing of CSFV E2 cloned in pUC vector (19) as starting material, DNase I partial digestion was conducted to enrich for in our laboratory (Fig. 1) . Furthermore, the only sequence variation in this region, i.e., the replacement of the Y random fragments in the range of 100-200 bp. After endrepairing, the blunt-ended small fragments were inserted residue in CSFV strains, at the second position of the YYEP tetra-peptide, by the F residue in some BVDV into the phage display vector fUSE1 (22), which was cut with PvuII and dephosphorylated with calf intestine alka-strains is in support of the finding obtained from the studies of random phage-displayed peptides as shown line phosphatase, to obtain a random epitope library containing approximately 5 1 10 5 independent phage clones.
in Fig. 2A .
In parallel, a third approach, utilizing a multipin peptide After two rounds of affinity selection using mAb 4-9D4, 8 positive clones were selected which displayed peptides synthesis system (25), was also used. Briefly, overlapping 8-mer peptides, offset by one, spanning residues 989-reactive with 4-9D4 in both ELISA and Western blot (data not shown). DNA sequencing analysis indicated that 7 1012 of CSFV E2 protein were synthesized on polyethylene pins with a linker allowing cleavage of the peptides of the 8 clones contained an identical insert coding for (numbers 2-6), which had significant binding to mAb 4-9D4, all shared the common sequence of YYEP. The C-ELISA analysis was carried out essentially as described in (27). Briefly, mAb 4-9D4 (1:100) was first incubated with individual peptides at 37Њ for 2 hr, spun for 10 min to remove any precipitated antigen/antibody complexes, then added to antigen-coated plates and incubated at 37Њ for 1 hr. Bound antibodies were detected as in I-ELISA. Again, only peptides 2-6 demonstrated strong competition (Fig. 3B) . These results not only indicated that the core tetra-peptide YYEP constitutes the discrete antibody binding site from mAb 4-9D4, but also demonstrated that mAb 4-9D4 could bind to YYEP-containing peptides either displayed on phage surface or in free solution. It is interesting to note that among the five positive peptides number 3 had the weakest binding in both I-and C-ELISA analyses. This might be due to its high content of positively charged residues (KNKYYEPR, 3/, 10), since the two flanking peptides carried less positive charge (peptide 2: 2/, 10; peptide 4: 2/, 20) and bind the mAb much better than peptide 3.
In summary, our data demonstrated that efficient and high resolution epitope mapping can be achieved using phage display technology. The complementary use of both gene-targeted epitope library and synthetic peptide FIG. 2. Sequence analysis of the 4-9D4 epitope. (A) Alignment of peptide sequences isolated from synthetic peptide phage display library. The top sequence (f1CSFV-D4) is the epitope fragment isolated from the E2-targeted phage display library, which corresponds to amino acid residues 991-1012 of the CSFV E2 protein (7, 19) . The 10 different 15-mer sequences derived from the random synthetic peptide library were given at the lower part of the figure, aligning the YYEP core consensus region. Identical amino acid residues to the top sequence are indicated by dots. (B) Comparison of pestivirus E2 sequences around the YYEP region. The amino acid sequences were obtained from GenBank database (as given by their accession numbers): Weybridge, X71780; Brescia, M31768; C, Z46758; GPE, D49533; LPC, U35740; ALD, D49532; Alfort, J044358; Singer, L12455; SD-1, M96751; Osloss, M96687; C24V, L07496; BD78, U18330. The NADL sequence was taken from (5). Amino acid residues identical to the top Weybridge sequence are indicated by dots.
(26). At the N-terminus of the peptide, a biotin tag and the 4-residue spacer (Ser-Gly-Ser-Gly) were incorporated while the C-terminus of the peptide was kept free. After synthesis, the peptides were cleaved into a physiologically compatible buffer (0.166 M phosphate, pH 8.0) and tested for their capacity to bind mAb 4-9D4 in both indirect ELISA (I-ELISA) and competition ELISA (C-ELISA). In the I-ELISA, the peptides (diluted 1:100 in PBST from a 1 mg/ml stock) were immobilized via the biotin tag onto a streptavidin-coated plate by incubation at 37Њ for 1 hr. The plate was then incubated with mAb 4-9D4 (1:50) at in Fig. 3A clearly demonstrated that the five peptides library further enhanced the usefulness of this new and REFERENCES powerful technology in epitope identification and charac-1. Francki, R. I. B., Faquet, C. M., Knudson, D. L., and Brown, F. (Eds.), terization. The use of synthetic peptides allowed us to Arch. Virol. Suppl. 2, 223-233 (1991). demonstrate the specific binding of mAb 4-9D4 to the 2. Moennig, V., and Plagemann, P. G. W., Adv. Virus Res. 41, core YYEP region within a totally different scaffold, i.e., (1992). peptides displayed on phage surface versus free pep-3. Wensvoort, G., Terpstra, C., De Kluijver, E. P., Kragten, C., and Warnaar, J. C., Vet. Microbiol. 21, 9-20 (1989). tides in solution.
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